VEGFA and metabolic syndrome: We then analyzed the synergistic effect of the VEGF polymorphisms and clinical factors (i.e., HTN, DM, hemoglobin A1c, smoking, BMI, hyperlipidemia, MetS, folate, and homocysteine) on CAD risk (Table S7).